Why is Balaxi Pharma falling/rising?

As of 02-Jul, Balaxi Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 49.07, which reflects a decrease of Rs. 0.94 or 1.88%. The stock has hit a new 52-week low of Rs. 48.53 today and has underperformed its sector by 0.65%. Over the past week, the stock has decreased by 1.76%, and its performance over the last month shows a significant drop of 7.48%. Additionally, the stock has generated a staggering return of -58.89% over the past year, indicating a troubling trend. Despite strong long-term fundamentals, including an average Return on Equity (ROE) of 30.97% and healthy growth rates in net sales and operating profit, the stock's recent performance has been negatively impacted by a flat PAT result and a substantial decline in profits over the past year.
In the broader market context, Balaxi Pharmaceuticals' short-term performance has been notably poor compared to the benchmark Sensex, which has risen by 0.83% in the last week. The stock's underperformance is further highlighted by its returns over the past three years, where it has lagged behind the BSE500 index. While there has been a rise in investor participation, as indicated by a significant increase in delivery volume, the overall sentiment remains bearish due to the stock's consistent underperformance and recent financial results. This combination of factors contributes to the stock's downward trajectory, making it less appealing to investors in the current market environment.